http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2512942-C9
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d25636878a0317ff98c25314aea7c00c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-273 |
| filingDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf095fa9692e43207892423097e6466a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bbcc5a6dda10f935744f82696eee152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7deba52e6439cccf4aab214473c5bfbe |
| publicationDate | 2015-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2512942-C9 |
| titleOfInvention | Method for prediction of developing and progressing ruflux oesophagitis |
| abstract | FIELD: medicine. n SUBSTANCE: what is involved is an endoscopic assessment of a degree of oesophageal involvement. The oesophagus is stained with 0.3% Congo red 2-3 ml through a spray catheter with maximum air insufflation. A length of the stained oesophageal segment (h) from a Z line with the stain colour changed by blue-black is measured in cm. Stain completeness coefficient K of an oesophageal circle is visually estimated as 1 for complete staining, and as 3/4, 1/2, 1/4 for partial staining. The derived data are used to calculate an area of the oesophageal involvement (S) by formula: S=2πrhK, wherein r=1 cm. If the patient shows no endoscopic signs of oesophagitis, though has pathologically acidic reflux oesophagitis with S>3.14 cm 2 , a high risk of degree I reflux oesophagitis is predicted. The value S>9.42 cm 2 in the patient degree I reflux oesophagitis enables predicting a high risk of a transformation into degree II reflux oesophagitis . n EFFECT: simple and information-bearing method enables the early detection of the patients relating to a risk of developing and progressing reflux esophagitis, provided prevention of developing and progressing organic changes of the oesophagus for the timely administration of a therapy. n 2 cl, 3 tbl, 2 ex |
| priorityDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.